Yumin Yang Selected Research

rhodioloside

1/2016	Salidroside improves glucose homeostasis in obese mice by repressing inflammation in white adipose tissues and improving leptin sensitivity in hypothalamus.
6/2014	2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside confers neuroprotection in cell and animal models of ischemic stroke through calpain1/PKA/CREB-mediated induction of neuronal glucose transporter 3.
4/2013	Synthesis and protective effects of novel salidroside analogues on glucose and serum depletion induced apoptosis in PC12 cells.
1/2013	Synthesis and neuroprotective effects of the fluorine substituted salidroside analogues in the PC12 cell model exposed to hypoglycemia and serum limitation.
9/2011	Synthesis and protective effects of aralkyl alcoholic 2-acetamido-2-deoxy-β-D-pyranosides on hypoglycemia and serum limitation induced apoptosis in PC12 cell.
8/2011	Neuroprotection against cobalt chloride-induced cell apoptosis of primary cultured cortical neurons by salidroside.
1/2011	Synthesis and biological evaluation of two salidroside analogues in the PC12 cell model exposed to hypoglycemia and serum limitation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yumin Yang Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 12/2013
7	Ischemic Stroke 11/2018 - 02/2011
5	Peripheral Nerve Injuries 04/2022 - 01/2012
5	Wounds and Injuries (Trauma) 10/2020 - 10/2009
3	Ischemia 09/2021 - 06/2014
3	Spinal Cord Injuries (Spinal Cord Injury) 04/2019 - 10/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2013 - 02/2011
3	Hypoglycemia (Reactive Hypoglycemia) 01/2013 - 01/2011
2	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2020
2	Liver Neoplasms (Liver Cancer) 10/2020 - 08/2015
2	Inflammation (Inflammations) 04/2019 - 01/2016
2	Contusions 04/2019 - 02/2013
2	Lacerations 01/2018 - 02/2013
1	Tuberous Sclerosis (Bourneville's Disease) 01/2022
1	Hypothyroidism 07/2021
1	Pain (Aches) 07/2021
1	Subacute Thyroiditis (Thyroiditis, De Quervain) 07/2021
1	Drug-Related Side Effects and Adverse Reactions 07/2021
1	Pathologic Constriction (Stenosis) 03/2021
1	Cognitive Dysfunction 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Colonic Neoplasms (Colon Cancer) 10/2020
1	Tissue Adhesions 04/2020
1	Brain Ischemia (Cerebral Ischemia) 11/2018
1	Stroke (Strokes) 11/2018
1	Infections 10/2016
1	Thrombocytopenia (Thrombopenia) 04/2016
1	Edema (Dropsy) 01/2016
1	Hyperglycemia 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Infarction (Infarctions) 01/2016

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 09/2021 - 08/2011
7	rhodiolosideIBA 01/2016 - 01/2011
5	ChitosanIBA 03/2021 - 10/2010
4	2- (4- methoxyphenyl)ethyl- 2- acetamido- 2- deoxyglucopyranosideIBA 09/2021 - 06/2014
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 06/2014
4	Neuroprotective AgentsIBA 04/2013 - 02/2011
3	Biological ProductsIBA 03/2021 - 01/2011
3	Pharmaceutical PreparationsIBA 10/2020 - 10/2009
3	HydrogelsIBA 04/2020 - 01/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 08/2011
2	Fibroins (Fibroin)IBA 01/2015 - 10/2009
2	thiazolyl blueIBA 08/2011 - 01/2011
1	Silk FDA Link 04/2022
1	arginyl-glycyl-aspartic acidIBA 04/2022
1	Sterol Regulatory Element Binding Protein 2IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	CholesterolIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	LipidsIBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Lidocaine (Xylocaine)FDA LinkGeneric 07/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2021
1	Triamcinolone (Aristocort)FDA Link 03/2021
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2021
1	GlucocorticoidsIBA 03/2021
1	CollagenIBA 03/2021
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 03/2021
1	MesothelinIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	PerforinIBA 01/2021
1	Granzymes (Granzyme)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 10/2020
1	piperlongumineIBA 10/2020
1	piperineIBA 10/2020
1	Thioredoxin-Disulfide ReductaseIBA 10/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2020
1	Glutathione (Reduced Glutathione)IBA 10/2020
1	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2020
1	Carbolines (Beta-Carbolines)IBA 10/2020
1	polyacrylamideIBA 04/2020
1	Tissue Adhesives (Tissue Adhesive)IBA 04/2020
1	AlginatesIBA 04/2020
1	Polysaccharides (Glycans)IBA 04/2020
1	CytokinesIBA 04/2019
1	Macrophage Migration-Inhibitory FactorsIBA 04/2019
1	Dinoprostone (PGE2)FDA Link 04/2019
1	GraphiteIBA 12/2017
1	Complement C3 (C3 Complement)IBA 04/2016
1	Piperacillin FDA LinkGeneric 04/2016
1	Tazobactam FDA LinkGeneric 04/2016
1	EnzymesIBA 01/2016
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2016
1	LeptinIBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2021 - 12/2015
2	Drug Therapy (Chemotherapy) 08/2016 - 12/2015
1	Duration of Therapy 07/2021
1	Microspheres (Microsphere) 03/2021
1	Immunotherapy 01/2021
1	Precision Medicine 10/2020
1	Tissue Scaffolds 10/2020
1	Debridement 06/2020
1	Autologous Transplantation 01/2018
1	Postoperative Care 10/2016